---
$id: https://graph.org.ai/products/commodity/51271904
$type: Product
source: UNSPSC
code: "51271904"
title: "Benoxinate or oxybuprocaine"
class: "51271900"
classTitle: "Anaesthetic aminobenzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Benoxinate or oxybuprocaine

**UNSPSC Code**: 51271904
**Class**: [Anaesthetic aminobenzoates](Anaesthetic aminobenzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C17H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AXQ0JYM303, chemically known as benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester (7ci,8ci,9ci) but generally known as benoxinate, which bears US NIH Compound Identifier 4633. Benoxinate most often comes in base and hydrochloride forms. European Medicines Agency schedules Oxybuprocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09557MIG. The term OXYBUPROCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules benoxinate in its Anatomical Therapeutic Chemical (ATC) Classification. Benoxinate or oxybuprocaine bears US NLM identifiers UMLS ID C0053114 and NCI Concept Code C72176. SMILES: CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.

